{"id":90643,"date":"2025-08-23T07:13:10","date_gmt":"2025-08-23T07:13:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/90643\/"},"modified":"2025-08-23T07:13:10","modified_gmt":"2025-08-23T07:13:10","slug":"ionis-gets-approval-for-preventing-attacks-in-rare-and-genetic-hae","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/90643\/","title":{"rendered":"Ionis gets approval for preventing attacks in rare and genetic HAE"},"content":{"rendered":"<p>In Ionis Pharmaceuticals Inc.\u2019s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as a prophylactic therapy in the rare and genetic disease hereditary angioedema (HAE). The approval came as scheduled as the NDA had a PDUFA date of Aug. 21. Dawnzera now joins a market with previously approved drugs for the rare, genetic, life-threatening condition, as well as other companies with HAE drugs in development.<\/p>\n<p><a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/84-bioworld\" rel=\"nofollow noopener\" target=\"_blank\">BioWorld<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/402-regulatory\" rel=\"nofollow noopener\" target=\"_blank\">Regulatory<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/242-dermatologic\" rel=\"nofollow noopener\" target=\"_blank\">Dermatologic<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/271-antisense\" rel=\"nofollow noopener\" target=\"_blank\">Antisense<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/433-fda\" rel=\"nofollow noopener\" target=\"_blank\">FDA<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"In Ionis Pharmaceuticals Inc.\u2019s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as&hellip;\n","protected":false},"author":2,"featured_media":90644,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[53430,53422,49,48,53427,53429,53426,2714,5306,316,53424,53423,53425,2992,53428,66],"class_list":{"0":"post-90643","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-antisense","9":"tag-bioworld","10":"tag-ca","11":"tag-canada","12":"tag-dawnzera","13":"tag-dermatologic","14":"tag-donidalorsen","15":"tag-fda","16":"tag-genetic-diseases","17":"tag-genetics","18":"tag-hereditary-angioedema","19":"tag-ionis-pharmaceuticals-inc","20":"tag-prophylactic-therapies","21":"tag-rare-disease","22":"tag-regulatory","23":"tag-science"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/90643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=90643"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/90643\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/90644"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=90643"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=90643"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=90643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}